Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| benign prostate tumors |
|
The Journal of Urology : Plasma Neuroendocrine Markers in Patients Approximately 50 percent of all malignant prostatic tumors contain in the normal prostate, benign prostatic hyperplasia (BPH) and primary or metastatic IngentaConnect Anti-Thrombin Is Expressed in the Benign Prostatic Abundant expression in a population of prostatic tumor cells was further Western blotting of benign and malignant tissue homogenates revealed a Tomatoes and Broccoli Slow Prostate Tumors in Animals - Prostate Other tumor-implanted rats were fed a normal diet but were given the drug finasteride, which is used to treat benign prostate enlargement, while others were Molecular Cancer | Full text | Hedgehog pathway activity in the The LADY tumor is a transgenic mouse model of prostate cancer in which the . prostate as well as benign prostatic hyperplasia and prostate cancer 9. Sensitivity of prostate tumors to wild type and M protein mutant We tested this hypothesis in the prostate tumor system by comparing LNCaP and PC-3 prostate tumor cells to benign human prostatic epithelial cells from Types of Prostate Cancer - WrongDiagnosis.com Cells from benign tumors do not spread to other parts of the body. Most important, benign tumors of the prostate are not a threat to life. WebMD Prostate Cancer Center - Find prostate cancer information Prostate cancer is diagnosed in an estimated 80% of men who reach age 80 Aspirin Limits Prostate Cancer Therapy · High-Carb Diet, Bigger Prostate Tumor? Anti-Thrombin Is Expressed in the Benign Prostatic Epithelium and -1-anti-chymotrypsin complexes are found in CAP than in benign prostatic hyperplasia (BPH), and this has become a widely used tool in tumor diagnosis.26,28 PET Imaging of Prostate Cancer with 11C-Acetate -- Dimitrakopoulou The authors noted a significant overlap of 18F-FDG uptake values in prostate tumors and benign prostate hyperplasia and concluded that 18F-FDG PET could not Prostate cancer is a malignancy that develops in the prostate The cells from benign tumors normally do not spread to other parts of the body. Benign tumors located in the prostate are usually not life threatening. Reductase Activity of 17β-Hydroxysteroid Oxidoreductase in with pathogenetic mechanisms of human malignant prostatic tumors. Key Words: prostatic cancer; benign prostatic hyperplasia; prostatic intraepithelial Prostate Cancer The three most common diseases which affect the prostate are benign prostatic growing and only in the local tissue and it is then called a BENIGN TUMOR. Prostate Cancer, Definitions, Seattle, Washington, Advanced A malignant tumor is cancer. A benign tumor is a growth that is not cancerous. It is usually used to treat BPH, or benign prostatic hyperplasia. benign Benign tumors may grow larger but do not spread to other parts of the body. Benign prostatic hypertrophy. A benign (noncancerous) condition in which Prostate Enlargement: Benign Prostatic Hyperplasia Doctors call this condition benign prostatic hyperplasia (BPH), or benign prostatic . To determine whether an abnormal-looking area is indeed a tumor, What You Need To Know About Prostate Cancer - National Cancer Cells from benign tumors do not invade the tissues around them. Benign prostatic hyperplasia (BPH) is the abnormal growth of benign prostate cells. Prostate Cancer: New Tests Create Treatment Dilemmas (FDA Consumer Prostate tumors are fueled by male hormones called androgens. acting up in less dangerous ways, the most common being benign prostate hyperplasia (BPH). FOCUS - May 6, 2005 - PATHOLOGY: Prostate Tumor Chemistry Reveals Prostate cancer defies easy definitionsâ”lethal for some, but benign for others. About 70 percent of newly diagnosed prostate tumors receive a Gleason Human Prostate Cancer and Benign Prostatic Hyperplasia: Molecular benign and malignant growth of the prostatic cells. Genomic instability of prostate tumors could lead to an extensive. variation in gene expression even |
| benign prostate tumors |
|
cancer in prostate surgery treatment angeles los massage prostate cancer lhrh luteinizing prostate trelstar capcure prostate cancer |